	Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer. Int J Part Ther Hasan S, Shen X, Giap H, Patel S, Hyde C, Deville C, Gray J, Simone CB, Mendenhall NP, Choi S, Bryant CM. PMID: 42028292 [PubMed]
	Deployment of a real-time prostate cancer confirmation system with Raman spectroscopy: fine-tuning versus test-time adaptation of 1D CNNs. Biophotonics Discov Grajales D, Le WT, Blanquez-Yeste V, Dallaire F, Azzi F, Delouya G, Trudel D, Leblond F, Ménard C, Kadoury S. PMID: 42028257 [PubMed]
	Diagnostic performance of apparent diffusion coefficients for prostate cancer in patients with PI-RADS 4-5 lesions: a retrospective analysis. Ther Adv Urol Bai X, Chen Y, Yuan L, Xu S, Zhu Z, Mo W, Xiao J, Wang C. PMID: 42027802 [PubMed]
	Assessing the density of lymph node metastasis in various inguinal regions of penile cancer using the nine-section method:Â A prospective study. Oncol Lett Hu C, Dai L, Wu H, Bai Y, Li J, Jiang H, Yin H, Bi Y, Wu W, Li R, Shi H. PMID: 42027639 [PubMed]
	Impact of asymptomatic bacteriuria on the outcomes and tolerability of Bacillus Calmette-GuÃ©rin immunotherapy. Scand J Urol Nummi A, Nurminen P, Kesti O, Högerman M, Ettala O, Boström PJ, Kaipia A, Sairanen J, Järvinen R. PMID: 42027190 [PubMed - indexed for MEDLINE]
	Impact of Preoperative Diagnosis of Overactive Bladder and Intravesical Prostatic Protrusion on Postoperative Overactive Bladder Symptom Improvement Following Robot-Assisted Radical Prostatectomy. Int J Urol Nakanishi Y, Okumura G, Ikezoe E, Gozu S, Imasato N, Hirose K, Kataoka M, Yajima S, Masuda H. PMID: 42026888 [PubMed - indexed for MEDLINE]
	Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trial. BMC Med Cai X, Zheng X, Wang D, Huang T, Peng Y, Zhang Z, Guo S, Han H, He L, Xu W, Zhou F, Jiang L, Dong P. PMID: 42026573 [PubMed - as supplied by publisher]
	Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. 2026. Eur Urol D'Andrea D, Soria F, Gontero P, Shariat SF. PMID: 42025515 [PubMed - as supplied by publisher]
	Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-Grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Eur Urol Piccolini A, Paciotti M, Buffi NM. PMID: 42025514 [PubMed - as supplied by publisher]
	Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial. JCO Glob Oncol Noronha V, Shah M, Kapoor A, Menon N, Patil V, Kurup AR, Dhar A, Goud S, More S, Yadav A, Agarwal A, Sable N, Chavan N, Pradosh A, Shirsat A, Gota V, Shetake A, Sharma S, Mishra BK, Gupta A, Sansar B, Sonawane S, Prabhash K. PMID: 42024845 [PubMed - indexed for MEDLINE]
	Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional Medicare. JCO Oncol Pract Jafry B, Lu CA, Ji J, Hu X, Bhanvadia R, Qin Q, Han X, Nipp RD, Shih YT, Yabroff KR, Zhang T, Jiang C. PMID: 42024832 [PubMed - as supplied by publisher]
	Evolution of survival outcomes in robot-assisted radical cystectomy over 20 years of experience in a high-volume tertiary robotic center. Minerva Urol Nephrol Resca S, Morra S, Frego N, Tamburini S, Ticonosco M, Pissavini A, Mourullo AN, Barletta F, Lambert E, D'Hondt F, DE Groote R, DE Naeyer G, Mottrie A. PMID: 42023750 [PubMed - indexed for MEDLINE]
	Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry. Minerva Urol Nephrol Ferriero M, Tuderti G, Proietti F, Chiacchio G, Bignante G, Wu Z, Wang L, Margulis V, Bhanvadia R, Abdollah F, Cusumano NB, Antonelli A, Ditonno F, Veccia A, Singla N, Brönimann S, Derweesh IH, Puri D, Meagher MF, Rais-Bahrami S, Moon SC, Ferro M, DE Cobelli O, Porpiglia F, Amparore D, Checcucci E, Lee R, Correa AF, Eun DD, Gonzalgo ML, Nativ OF, Perdonà S, Tufano A, Eraky A, Mehrazin R, Yong C, Sundaram CP, Yoshida T, Kinoshita H, Ghoreifi A, Moghaddam FS, Djaladat H, Autorino R, Simone G. PMID: 42023749 [PubMed - indexed for MEDLINE]
	Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study). Minerva Urol Nephrol Maruzzo M, Poprach A, Buti S, Bamias A, Zakopoulou R, DE Giorgi U, Kucharz J, Formisano L, Buttner T, Zucali PA, Li H, Incorvaia L, Kopp RM, Messina C, Kopecky J, Fornarini G, Landmesser J, Rebuzzi SE, Nasso C, Fay AP, Bhuva D, Pinto A, Buchler T, Pichler R, Kanesvaran R, Soares A, Massari F, Monteiro FS, Dos Santos Filho IA, Porta C, Basso U, Santoni M. PMID: 42023748 [PubMed - indexed for MEDLINE]
	Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic review. Minerva Urol Nephrol DI Trapani E, Lo Giudice A, Mazzone E, Dell'oglio P, Sorce G, Luzzago S, Mistretta FA, LA Croce G, Piccinelli M, DI Trapani D, Moschini M, Galfano A, Montorsi F, Briganti A, Abdollah F, DE Cobelli O, Musi G. PMID: 42023746 [PubMed - indexed for MEDLINE]
	Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in people undergoing radical cystectomy. Cochrane Database Syst Rev Lee CH, Shepherd A, Sathianathen N, Hwang JE, Hwang EC, Kim MH, Narayan V, Jung JH, Dahm P. PMID: 42023708 [PubMed - indexed for MEDLINE]
	Characteristics and therapeutic resistance mechanisms of the prostate cancer immune microenvironment: a comprehensive analysis from bench to clinic. Front Pharmacol Li J, Wang X, Tang X. PMID: 42022555 [PubMed]
	Comparison of the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy: A network meta-analysis. Asia Pac J Oncol Nurs Quan L, Zhang Y, Wu S, Hou S, Li K, Tian W, Wang W. PMID: 42022295 [PubMed]
	Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naÃ¯ve non-muscle invasive bladder cancer: Systematic review and meta-analysis. BJUI Compass Titus RS, Riveros C, Velasquez EL, Nguyen DD, Somawardana S, Singh A, Kaushik D, Sonpavde G, Zlotta A, Kulkarni G, Sridhar SS, Wallis CJD, Satkunasivam R. PMID: 42022227 [PubMed]
	Diagnostic and therapeutic challenges in intradiverticular bladder carcinoma: A case report. Urol Case Rep Manoj A, Chakraborty S, Kantha A, Pandey M. PMID: 42021970 [PubMed]

Articles 1 - 20 / 177708

Page 1 of 8886



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy